Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, not just today’s reading.
Reader sentiment, not investment advice. One vote per visitor; click again to change it.
LH last changed hands at $307.90 (down 0.07%). At $24.97B, Labcorp Holdings is ranked #498 by size among the 800 stocks on BeStock.
Over the past 52 weeks it has traded between $242.07 and $341.06, so it sits 9.7% below the top of that range. Holders are ahead 11.5% over twelve months, and up 8.7% across the last three months.
Price is below the 50-day average ($318.17) but above the 200-day ($278.81); RSI is 41, and the last 30 sessions moved at roughly 24% annualized volatility.
For the quarter ended Jun 2026 it reported $3.73B in revenue, up 5.8% from a year earlier, with $299.10M of net profit (a 7.0% margin).
The stock changes hands at 25.5 times trailing earnings, about in line with its own five-year average of 24.8. The median for its industry group is 39.9.
12 analysts follow the stock and the average call is "buy". The mean target, $347.67, sits 12.9% over where the stock trades.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Composite of 4 factors below, ranked against the 800 U.S. stocks BeStock covers.
Cheaper than usual on its own 5-year P/E history scores higher.
Higher trailing yield than most of BeStock’s coverage scores higher.
Trading closer to its 52-week high than most peers scores higher.
12 analysts, consensus Buy.
How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.
LH is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.
Since 2020-07-06, the strategy has returned 1524.8% (321.7% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated weekly — not a guarantee of future results, and not a BeStock recommendation.
What Wall Street analysts and Morningstar's fair-value model expect for the stock
Wall Street’s average 12-month target is $347.67, 12.9% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $293.00, so shares trade 5.1% above that estimate. On earnings multiple, it sits in the 51st percentile of its own five-year valuation range (pricier than usual).
Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.
Price return over each window, from adjusted daily and weekly closes
| Indicator | Value | Signal |
|---|---|---|
| Price vs 20-day average | -2.9% | Bearish |
| Price vs 50-day average | -3.2% | Bearish |
| Price vs 200-day average | +10.4% | Bullish |
| 50-day vs 200-day | 50d above 200d | Bullish |
| RSI (14) | 40.8 | Bearish |
| MACD (12,26,9) | -3.15 | Bearish |
| Bollinger band position | 23% | Bearish |
Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.
Quote as of Oct 1, 2026 11:50 am ET. Prices can lag the live tape. This is background information, not a recommendation.
Ranks are among the 800 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.
Set against the peer table: at 25.5x earnings, LH looks about mid-pack against the market, and trades 36% below the 39.9x median among Diagnostics & Research names. The two comparisons do not always agree.
$307.90 is the latest print for LH, a move of -0.07% against yesterday's close of $308.11. Today's low and high so far: $304.14 and $309.40.
Equity value comes to $24.97B at the current price. By that measure it is number 498 of the 800 names in our coverage.
Buyers pay 25.5 times the last twelve months of profit (EPS $10.46). Averaged over five years the multiple has been 24.8, and today's level ranks in the 51st percentile of its own history.
The year's floor is $242.07 and the ceiling $341.06. Shares are 9.7% away from that ceiling.
It does. Payouts over the past twelve months work out to a 0.94% yield; the latest ex-dividend date was August 28, 2026.
Of 12 analysts, 83% say buy, 17% hold and 0% sell. Price targets average $347.67, with the most cautious at $309.00 and the most optimistic at $380.00.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.
No comments yet — be the first to weigh in on LH.